Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | ALPI | P09923 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17355681 | 0.80 | PTGS2 (0.36) | KMT2ASMN1; SMN2NFE2L2ALDH1A1NPC1 | |
| SCHEMBL6905828 | 0.79 | ALDH1A1 (0.49) | MCL1KMT2AMEN1PKMSMN1; SMN2 | |
| SCHEMBL17352170 | 0.76 | CA1 (0.45) | POLBGPR84 | |
| SCHEMBL22337364 | 0.74 | CA2 (0.55) | KMT2AMEN1SMN1; SMN2NFE2L2ALDH1A1 | |
| SCHEMBL11521115 | 0.74 | CA2 (0.55) | KMT2AMEN1SMN1; SMN2NFE2L2ALDH1A1 | |
| SCHEMBL11628311 | 0.72 | NFE2L2 (0.51) | KMT2AMEN1SMN1; SMN2NFE2L2ALDH1A1 | |
| SCHEMBL3271477 | 0.72 | CA1 (0.54) | KMT2AMEN1SMN1; SMN2NFE2L2ALDH1A1 | |
| SCHEMBL17355706 | 0.72 | KMT2A (0.55) | KMT2AMEN1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL7249134 | 0.72 | TDP1 (0.60) | MCL1KMT2AMEN1PKMSMN1; SMN2 | |
| SCHEMBL17355739 | 0.71 | MCL1 (0.53) | MCL1KMT2AMEN1PKMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | UBE INDUSTRIES, LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | HCN2, SCO2, HCN1 | MCL1 4249/4885KMT2A 2355/4885MEN1 4646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.